{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:38Z","timestamp":1790356058524,"version":"4.1.0"},"reference-count":179,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.heliyon.2022.e11119","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:55:01Z","timestamp":1666068901000},"page":"e11119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Deciphering the role of aberrant DNA methylation in NAFLD and NASH"],"prefix":"10.1016","volume":"8","author":[{"given":"Meenakshi","family":"Vachher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8256-6344","authenticated-orcid":false,"given":"Archana","family":"Burman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.heliyon.2022.e11119_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib5","article-title":"Effect of cofactors on NAFLD\/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction","volume":"2","author":"Lonardo","year":"2022","journal-title":"Metab Target Organ Damage"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/ijbs.29599","article-title":"Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer","volume":"15","author":"Divella","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"1 Pt 1","key":"10.1016\/j.heliyon.2022.e11119_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jfma.2020.07.006","article-title":"Non-alcoholic fatty liver disease: a review with clinical and pathological correlation","volume":"120","author":"Chen","year":"2021","journal-title":"J.\u00a0Formos. Med. Assoc."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib8","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J.\u00a0Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijmr.IJMR_1456_17","article-title":"Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: an increasing concern","volume":"149","author":"Dhamija","year":"2019","journal-title":"Indian J. Med. Res."},{"issue":"22","key":"10.1016\/j.heliyon.2022.e11119_bib10","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.4254\/wjh.v7.i22.2384","article-title":"Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: potential mechanistic pathways","volume":"7","author":"Perumpail","year":"2015","journal-title":"World J. Hepatol."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080845","article-title":"Current status in testing for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)","volume":"8","author":"Drescher","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2022.e11119_bib12","unstructured":"National Guideline Centre (UK). Non-Alcoholic Fatty Liver Disease: Assessment And Management 2016: London."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041005","article-title":"Noninvasive diagnosis of NAFLD and NASH","volume":"9","author":"Piazzolla","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jceh.2018.04.001","article-title":"Genetic and epigenetic culprits in the pathogenesis of nonalcoholic fatty liver disease","volume":"8","author":"Kovalic","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030911","article-title":"Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD)","volume":"19","author":"Del Campo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet."},{"issue":"45","key":"10.1016\/j.heliyon.2022.e11119_bib18","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.3748\/wjg.v18.i45.6546","article-title":"Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease","volume":"18","author":"Li","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.tcb.2019.11.006","article-title":"Epigenetic regulation of mesenchymal stem cell homeostasis","volume":"30","author":"Sui","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/epi.11.22","article-title":"Epigenetics and lifestyle","volume":"3","author":"Alegria-Torres","year":"2011","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib23","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40519-014-0129-0","article-title":"Which metabolic syndrome criteria best predict non-alcoholic fatty liver disease in children?","volume":"19","author":"Atabek","year":"2014","journal-title":"Eat. Weight Disord."},{"key":"10.1016\/j.heliyon.2022.e11119_bib28","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J.\u00a0Diabetes Res."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.sempedsurg.2013.10.016","article-title":"Nonalcoholic fatty liver disease and bariatric surgery in adolescents","volume":"23","author":"Holterman","year":"2014","journal-title":"Semin. Pediatr. Surg."},{"key":"10.1016\/j.heliyon.2022.e11119_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2431-13-115","article-title":"Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth","volume":"13","author":"Silveira","year":"2013","journal-title":"BMC Pediatr."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib31","first-page":"1375","article-title":"Advances in pediatric nonalcoholic fatty liver disease","volume":"58","author":"Mencin","year":"2011","journal-title":"Pediatr. Clin."},{"key":"10.1016\/j.heliyon.2022.e11119_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30252","article-title":"Contribution of organokines in the development of NAFLD\/NASH associated hepatocellular carcinoma","author":"Vachher","year":"2022","journal-title":"J.\u00a0Cell. Biochem."},{"issue":"16","key":"10.1016\/j.heliyon.2022.e11119_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165888","article-title":"History of nonalcoholic fatty liver disease","volume":"21","author":"Lonardo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib35","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s12325-017-0556-1","article-title":"NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk","volume":"34","author":"Ballestri","year":"2017","journal-title":"Adv. Ther."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib36","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/157339912799424564","article-title":"Over-nutrition, obesity and insulin resistance in the development of beta-cell dysfunction","volume":"8","author":"Gupta","year":"2012","journal-title":"Curr. Diabetes Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib40","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Trepo","year":"2020","journal-title":"J.\u00a0Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib41","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2020.01.053","article-title":"Toward genetic prediction of nonalcoholic fatty liver disease trajectories: PNPLA3 and beyond","volume":"158","author":"Krawczyk","year":"2020","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11119_bib43","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/liv.12970","article-title":"Heterogeneity of non-alcoholic fatty liver disease","volume":"35","author":"Yki-Jarvinen","year":"2015","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib44","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J.\u00a0Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/hep.31238","article-title":"Combined effect of PNPLA3, TM6SF2, and HSD17B13 variants on risk of cirrhosis and hepatocellular carcinoma in the general population","volume":"72","author":"Gellert-Kristensen","year":"2020","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J.\u00a0Lipid Res."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib49","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41588-018-0084-1","article-title":"Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib50","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1172\/JCI30706","article-title":"Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes","volume":"117","author":"Lyssenko","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051260","article-title":"Association of the SH2B1 rs7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease","volume":"12","author":"Perez-Diaz-Del-Campo","year":"2020","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.22659","article-title":"Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH","volume":"49","author":"Musso","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.gene.2013.09.012","article-title":"Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population","volume":"532","author":"Ramya","year":"2013","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib54","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.2337\/db07-1807","article-title":"The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population","volume":"57","author":"Vaxillaire","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib55","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091314","article-title":"Dissociation of fatty liver and insulin resistance in I148M PNPLA3 carriers: differences in diacylglycerol (DAG) FA18:1 lipid species as a possible explanation","volume":"10","author":"Franko","year":"2018","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2021","journal-title":"J.\u00a0Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib58","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gutjnl-2016-311526","article-title":"Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease","volume":"66","author":"Hardy","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib59","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jhep.2013.07.011","article-title":"Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation","volume":"59","author":"Cao","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.heliyon.2022.e11119_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib61","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2008.08.012","article-title":"Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet","volume":"49","author":"Ahn","year":"2008","journal-title":"J.\u00a0Hepatol."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib62","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.2337\/db14-0263","article-title":"SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis","volume":"63","author":"Xu","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/C8MO00214B","article-title":"Gene expression profile-based drug screen identifies SAHA as a novel treatment for NAFLD","volume":"15","author":"Cheng","year":"2019","journal-title":"Mol Omics"},{"key":"10.1016\/j.heliyon.2022.e11119_bib64","article-title":"An update in epigenetics in metabolic-associated fatty liver disease","volume":"8","author":"Rodriguez-Sanabria","year":"2021","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib65","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s12325-021-01690-1","article-title":"Perspectives on precision medicine approaches to NAFLD diagnosis and management","volume":"38","author":"Lonardo","year":"2021","journal-title":"Adv. Ther."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11119_bib66","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib67","first-page":"246","article-title":"Role of epigenetics in biology and human diseases","volume":"20","author":"Moosavi","year":"2016","journal-title":"Iran. Biomed. J."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib68","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.febslet.2009.04.012","article-title":"CpG islands--'a rough guide'","volume":"583","author":"Illingworth","year":"2009","journal-title":"FEBS Lett."},{"issue":"14","key":"10.1016\/j.heliyon.2022.e11119_bib69","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1002\/1522-2683(200108)22:14<2838::AID-ELPS2838>3.0.CO;2-M","article-title":"DNA methylation and mammalian epigenetics","volume":"22","author":"Reik","year":"2001","journal-title":"Electrophoresis"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib70","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00018-008-8432-4","article-title":"Epigenetic mechanisms in mammals","volume":"66","author":"Kim","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib71","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.biochi.2012.05.016","article-title":"Mechanisms of DNA methylation and demethylation in mammals","volume":"94","author":"Auclair","year":"2012","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3945\/an.110.1004","article-title":"Epigenetics: a new bridge between nutrition and health","volume":"1","author":"Choi","year":"2010","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","article-title":"Genomic DNA methylation: the mark and its mediators","volume":"31","author":"Klose","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib74","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/15592294.2019.1595297","article-title":"DNA methylation markers in obesity, metabolic syndrome, and weight loss","volume":"14","author":"Samblas","year":"2019","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib75","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib76","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00412-009-0221-9","article-title":"DNA methylation and methyl-CpG binding proteins:\u00a0developmental requirements and function","volume":"118","author":"Bogdanovic","year":"2009","journal-title":"Chromosoma"},{"issue":"1-2","key":"10.1016\/j.heliyon.2022.e11119_bib77","first-page":"30","article-title":"DNA methylation in development and human disease","volume":"647","author":"Gopalakrishnan","year":"2008","journal-title":"Mutat. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: a versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11119_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/genes9120620","article-title":"Structural basis of DNMT1 and DNMT3A-mediated DNA methylation","volume":"9","author":"Ren","year":"2018","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib80","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/epi.13.69","article-title":"5-hydroxymethylcytosine profiling as an indicator of cellular state","volume":"5","author":"Laird","year":"2013","journal-title":"Epigenomics"},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib81","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1093\/nar\/gkt232","article-title":"Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver","volume":"41","author":"Thomson","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib82","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e11119_bib83","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.15252\/embj.201488290","article-title":"Playing TETris with DNA modifications","volume":"33","author":"Delatte","year":"2014","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11119_bib84","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e11119_bib85","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218138","article-title":"DNA methylation in nonalcoholic fatty liver disease","volume":"21","author":"Hyun","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2022.e11119_bib86","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fgene.2013.00002","article-title":"Molecular interactions between NAFLD and xenobiotic metabolism","volume":"4","author":"Naik","year":"2013","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib87","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep.21650","article-title":"Role of S-adenosyl-L-methionine in liver health and injury","volume":"45","author":"Mato","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2022.e11119_bib88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1475-2891-12-37","article-title":"Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"de Carvalho","year":"2013","journal-title":"Nutr. J."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib89","doi-asserted-by":"crossref","first-page":"e0136822","DOI":"10.1371\/journal.pone.0136822","article-title":"Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease","volume":"10","author":"Pacana","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib90","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/oby.22667","article-title":"Association of hepatic global DNA methylation and serum one-carbon metabolites with histological severity in patients with NAFLD","volume":"28","author":"Lai","year":"2020","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib91","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2012-302962","article-title":"Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease","volume":"62","author":"Pirola","year":"2013","journal-title":"Gut"},{"issue":"36","key":"10.1016\/j.heliyon.2022.e11119_bib92","doi-asserted-by":"crossref","first-page":"e1480","DOI":"10.1097\/MD.0000000000001480","article-title":"Epigenetic modifications in the biology of nonalcoholic fatty liver disease: the role of DNA hydroxymethylation and TET proteins","volume":"94","author":"Pirola","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib93","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/abbs\/gmr007","article-title":"PGC-1 coactivators in the control of energy metabolism","volume":"43","author":"Liu","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib94","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/hep.23927","article-title":"Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: impact of liver methylation of the peroxisome proliferator-activated receptor gamma coactivator 1alpha promoter","volume":"52","author":"Sookoian","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2217\/epi.09.14","article-title":"Genome-wide DNA methylation profiling using Infinium(R) assay","volume":"1","author":"Bibikova","year":"2009","journal-title":"Epigenomics"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib96","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metabol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib97","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.bbalip.2016.12.005","article-title":"NAFLD is associated with methylation shifts with relevance for the expression of genes involved in lipoprotein particle composition","volume":"1862","author":"Mwinyi","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.heliyon.2022.e11119_bib98","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12864-016-2814-z","article-title":"A\u00a0targeted analysis reveals relevant shifts in the methylation\u00a0and transcription of genes responsible for bile acid homeostasis and\u00a0drug metabolism in non-alcoholic fatty liver disease","volume":"17","author":"Schioth","year":"2016","journal-title":"BMC Genom."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11119_bib99","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and\u00a0non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metabol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2337\/db15-1716","article-title":"Hepatic DPP4 DNA methylation associates with fatty liver","volume":"66","author":"Baumeier","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib101","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.dld.2021.05.013","article-title":"Genome-wide DNA methylation profiling in nonalcoholic fatty liver reveals predictive aberrant methylation in PRKCE and SEC14L3 promoters","volume":"54","author":"Pan","year":"2022","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib102","first-page":"443","article-title":"Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease","volume":"42","author":"Zhang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2022.e11119_bib103","first-page":"6946","article-title":"Altered DNA methylation sites in peripheral blood leukocytes from patients with simple steatosis and nonalcoholic steatohepatitis (NASH)","volume":"24","author":"Wu","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib104","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2337\/db18-1193","article-title":"A\u00a0peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease","volume":"68","author":"Ma","year":"2019","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib105","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1053\/j.gastro.2017.06.003","article-title":"Epigenome-wide association study identifies methylation sites associated with liver enzymes and hepatic steatosis","volume":"153","author":"Nano","year":"2017","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib106","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1101\/gr.5217506","article-title":"Tissue-specific expression and regulation of sexually dimorphic genes in mice","volume":"16","author":"Yang","year":"2006","journal-title":"Genome Res."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib107","article-title":"Sexual dimorphism of NAFLD in adults. Focus on clinical aspects and implications for practice and translational research","volume":"9","author":"Lonardo","year":"2020","journal-title":"J.\u00a0Clin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: a systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib109","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/liv.14652","article-title":"The association of sex steroid hormone concentrations with non-alcoholic fatty liver disease and liver enzymes in US men","volume":"41","author":"Phan","year":"2021","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib110","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep4.1668","article-title":"Sex and menopause modify the effect of single nucleotide polymorphism genotypes on fibrosis in NAFLD","volume":"5","author":"Wegermann","year":"2021","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092502","article-title":"Beyond the X Factor: relevance of sex hormones in NAFLD pathophysiology","volume":"10","author":"Della Torre","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib112","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.mce.2013.11.003","article-title":"Expression and methylation status of female-predominant GH-dependent liver genes are modified by neonatal androgenization in female mice","volume":"382","author":"Ramirez","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib113","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.taap.2015.02.021","article-title":"Developmental bisphenol A (BPA) exposure leads to sex-specific modification of hepatic gene expression and epigenome at birth that may exacerbate high-fat diet-induced hepatic steatosis","volume":"284","author":"Strakovsky","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib114","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41374-018-0144-2","article-title":"Sex-associated preventive effects of low-dose aspirin on obesity and non-alcoholic fatty liver disease in mouse offspring with over-nutrition in utero","volume":"99","author":"Zhou","year":"2019","journal-title":"Lab. Invest."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96685","article-title":"DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis","volume":"3","author":"Loomba","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"5532","key":"10.1016\/j.heliyon.2022.e11119_bib117","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1063443","article-title":"Epigenetic reprogramming in mammalian development","volume":"293","author":"Reik","year":"2001","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib118","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.11.024","article-title":"Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape","volume":"64","author":"Page","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.heliyon.2022.e11119_bib119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13148-015-0056-6","article-title":"Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"7","author":"Zeybel","year":"2015","journal-title":"Clin. Epigenet."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib120","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2015.02.049","article-title":"Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease","volume":"63","author":"Kitamoto","year":"2015","journal-title":"J.\u00a0Hepatol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib121","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib122","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13148-021-01129-y","article-title":"Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD","volume":"13","author":"Johnson","year":"2021","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.heliyon.2022.e11119_bib123","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/ncomms4083","article-title":"Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease","volume":"5","author":"Mardinoglu","year":"2014","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib124","doi-asserted-by":"crossref","first-page":"e0204308","DOI":"10.1371\/journal.pone.0204308","article-title":"Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: a pilot study","volume":"13","author":"Wegermann","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/carcin\/bgw060","article-title":"Liver carcinogenesis: from naughty chemicals to soothing fat and the surprising role of NRF2","volume":"37","author":"Karin","year":"2016","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib126","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib127","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2022.e11119_bib128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3389\/fgene.2019.00486","article-title":"Gene expression and DNA methylation alterations during non-alcoholic steatohepatitis-associated liver carcinogenesis","volume":"10","author":"Dreval","year":"2019","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib129","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1242\/jcs.199471","article-title":"The tubulin code at a glance","volume":"130","author":"Gadadhar","year":"2017","journal-title":"J.\u00a0Cell Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4161\/cbt.6.5.3955","article-title":"Expression profiling reveals dysregulation of cellular cytoskeletal genes in HBx-induced hepatocarcinogenesis","volume":"6","author":"Sun","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/toxsci\/kfz110","article-title":"Gene expression and DNA methylation alterations in the Glycine N-methyltransferase gene in diet-induced nonalcoholic fatty liver disease-associated carcinogenesis","volume":"170","author":"Borowa-Mazgaj","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib132","first-page":"552","article-title":"Alterations of methionine metabolism in hepatocarcinogenesis: the emergent role of glycine N-methyltransferase in liver injury","volume":"31","author":"Simile","year":"2018","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.heliyon.2022.e11119_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114607","article-title":"Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma","volume":"378","author":"Chen","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib134","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.22159","article-title":"Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice","volume":"47","author":"Martinez-Chantar","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10930-w","article-title":"Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis","volume":"7","author":"Ryaboshapkina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2022.e11119_bib136","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3389\/fmed.2019.00304","article-title":"PNPLA3-A potential therapeutic target for personalized treatment of chronic liver disease","volume":"6","author":"Dong","year":"2019","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib137","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/jgh.13318","article-title":"Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease","volume":"31","author":"Nishida","year":"2016","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib138","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12876-022-02360-4","article-title":"Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma","volume":"22","author":"Kurokawa","year":"2022","journal-title":"BMC Gastroenterol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e11119_bib139","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00432-020-03298-4","article-title":"Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas","volume":"146","author":"Tian","year":"2020","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib140","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1172\/JCI89444","article-title":"Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance","volume":"127","author":"Hernandez","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib141","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3945\/ajcn.2008.27296","article-title":"High protein intake reduces intrahepatocellular lipid deposition in humans","volume":"90","author":"Bortolotti","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11119_bib142","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1210\/jc.2019-00160","article-title":"Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial","volume":"104","author":"Rosqvist","year":"2019","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e11119_bib143","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.2337\/dc18-0071","article-title":"Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars","volume":"41","author":"Luukkonen","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib144","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.CIR.0000019552.77778.04","article-title":"Sugar and cardiovascular disease: a statement for healthcare professionals from the committee on nutrition of the council on nutrition, physical activity, and metabolism of the American heart association","volume":"106","author":"Howard","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib145","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: a major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J.\u00a0Hepatol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib146","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/j.gastro.2016.10.007","article-title":"Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes","volume":"152","author":"Markova","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib147","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hep4.1509","article-title":"High protein intake is associated with histological disease activity in patients with NAFLD","volume":"4","author":"Lang","year":"2020","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib148","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3945\/ajcn.114.104976","article-title":"Red meat, dairy, and insulin sensitivity: a randomized crossover intervention study","volume":"101","author":"Turner","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib149","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2018.01.015","article-title":"High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance","volume":"68","author":"Zelber-Sagi","year":"2018","journal-title":"J.\u00a0Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.heliyon.2022.e11119_bib150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/liv.14360","article-title":"The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management","volume":"40","author":"Berna","year":"2020","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib151","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J.\u00a0Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib152","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2337\/dc12-0033","article-title":"Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients","volume":"35","author":"Bozzetto","year":"2012","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib153","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091256","article-title":"Dietary patterns influence target gene expression through emerging epigenetic mechanisms in nonalcoholic fatty liver disease","volume":"9","author":"Zaiou","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib154","first-page":"328","article-title":"Nutriepigenomics: the role of nutrition in epigenetic control of human diseases","volume":"18","author":"Remely","year":"2015","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib155","doi-asserted-by":"crossref","first-page":"e0175675","DOI":"10.1371\/journal.pone.0175675","article-title":"Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations","volume":"12","author":"Wankhade","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.heliyon.2022.e11119_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101102","article-title":"High glucose induces lipid accumulation via 25-hydroxycholesterol DNA-CpG methylation","volume":"23","author":"Wang","year":"2020","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib157","doi-asserted-by":"crossref","first-page":"E1369","DOI":"10.1152\/ajpendo.90555.2008","article-title":"25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR\/SREBP-1 signaling pathway","volume":"295","author":"Ma","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"4-6","key":"10.1016\/j.heliyon.2022.e11119_bib158","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000324362","article-title":"Dietary methyl deficiency, microRNA expression and susceptibility to liver carcinogenesis","volume":"3","author":"Starlard-Davenport","year":"2010","journal-title":"J.\u00a0Nutrigenetics Nutrigenomics"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib159","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mnfr.201000300","article-title":"Coupling global methylation and gene expression profiles reveal key pathophysiological events in liver injury induced by a methyl-deficient diet","volume":"55","author":"Tryndyak","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e11119_bib160","doi-asserted-by":"crossref","first-page":"24422","DOI":"10.3390\/ijms141224422","article-title":"Maternal methyl donors supplementation during lactation prevents the hyperhomocysteinemia induced by a high-fat-sucrose intake by dams","volume":"14","author":"Cordero","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib161","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12263-012-0300-z","article-title":"Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet","volume":"8","author":"Cordero","year":"2013","journal-title":"Genes Nutr"},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib162","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3945\/jn.111.151753","article-title":"Disturbed one-carbon metabolism causing adverse reproductive outcomes in mice is associated with altered expression of apolipoprotein AI and inflammatory mediators PPARalpha, interferon-gamma, and interleukin-10","volume":"142","author":"Mikael","year":"2012","journal-title":"J.\u00a0Nutr."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e11119_bib163","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jnutbio.2013.11.007","article-title":"Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet","volume":"25","author":"Wang","year":"2014","journal-title":"J.\u00a0Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e11119_bib164","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1530-0277.2008.00892.x","article-title":"Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease","volume":"33","author":"Zivkovic","year":"2009","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e11119_bib165","first-page":"323","article-title":"Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates","volume":"119","author":"McCurdy","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.heliyon.2022.e11119_bib166","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molmet.2018.09.008","article-title":"Switching obese mothers to a healthy diet improves fetal hypoxemia, hepatic metabolites, and lipotoxicity in non-human primates","volume":"18","author":"Wesolowski","year":"2018","journal-title":"Mol. Metabol."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e11119_bib167","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1007\/s00018-019-03114-4","article-title":"Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease","volume":"76","author":"Kim","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e11119_bib168","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jhep.2009.12.042","article-title":"Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice","volume":"52","author":"Oben","year":"2010","journal-title":"J.\u00a0Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021662","article-title":"Offspring of mothers fed a high fat diet display hepatic cell cycle inhibition and associated changes in gene expression and DNA methylation","volume":"6","author":"Dudley","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.heliyon.2022.e11119_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108319","article-title":"The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet","volume":"77","author":"Chen","year":"2020","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.heliyon.2022.e11119_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1-2","key":"10.1016\/j.heliyon.2022.e11119_bib172","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15592294.2019.1649527","article-title":"Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation","volume":"15","author":"Lyall","year":"2020","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib173","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","article-title":"Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet","volume":"51","author":"Pogribny","year":"2009","journal-title":"J.\u00a0Hepatol."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e11119_bib174","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071534","article-title":"A\u00a0nutrigenomic approach to non-alcoholic fatty liver disease","volume":"18","author":"Dongiovanni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib175","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/apha.12414","article-title":"Exercise training and DNA methylation in humans","volume":"213","author":"Voisin","year":"2015","journal-title":"Acta Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib176","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13578-021-00701-6","article-title":"Effect of exercise and diet intervention in NAFLD and NASH via GAB2 methylation","volume":"11","author":"Wu","year":"2021","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e11119_bib177","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/liv.14916","article-title":"Effects of lifestyle interventions on epigenetic signatures of liver fat: central randomized controlled trial","volume":"41","author":"Yaskolka Meir","year":"2021","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e11119_bib178","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/15592294.2016.1261239","article-title":"High fat diet and exercise lead to a disrupted and pathogenic DNA methylome in mouse liver","volume":"12","author":"Zhou","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/j.heliyon.2022.e11119_bib179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.11.015","article-title":"Physical exercise and liver \"fitness\": role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease","volume":"32","author":"Stevanovic","year":"2020","journal-title":"Mol. Metabol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022024070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022024070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:35:30Z","timestamp":1790354130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022024070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":179,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2405844022024070"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11119","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering the role of aberrant DNA methylation in NAFLD and NASH","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e11119"}}